| Similar Articles |
|---|
 |
The Motley Fool
October 7, 2004
Charly Travers |
Santarus Takes on Big Pharma Can this small drug company compete with the industry's giants? Santarus bolstered its marketing efforts with the signing of a very beneficial partnership with Otsuka America Pharmaceutical.   |
The Motley Fool
April 27, 2004
Charly Travers |
More Biotech IPOs Can small biotech take on big pharma? You bet. A new biotech company decides to use its technology to battle large pharma head on. If all goes well, this could be one of the biggest drug development stories of the year. |
The Motley Fool
December 3, 2009
Brian Orelli |
I Love This Industry With double-digit gains, how could you not love the biotech industry? |
The Motley Fool
June 17, 2004
Charly Travers |
No Heartburn for Santarus As a small company, Santarus is definitely going to have its hands full marketing the new heartburn drug Rapinex against some of the biotech giants. |
The Motley Fool
June 22, 2010
Dave Mock |
A Big Upgrade for DepoMed This bullish call comes from more than just one analyst. |
